Ingram Douglas S
CIK 0001190644
President & CEODirector
Filings
8
Latest Dec 18, 2025
Issuers covered
3
Showing
8 of 8
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 100% | +10.4% | +10.4% | +10.4% | +10.4% |
| 90 days | 4 | 100% | +57.5% | +57.5% | +57.5% | +57.5% |
| 180 days | 4 | 100% | +67.8% | +67.8% | +67.8% | +67.8% |
| 365 days | 4 | 100% | +57.8% | +57.8% | +57.8% | +57.8% |
Issuers
Companies where Ingram Douglas S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | 4 | Jun 6, 2025 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 2 | Dec 18, 2025 |
| SRPT | Sarepta Therapeutics, Inc. | 2 | Dec 9, 2025 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|